Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.
ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.
Investor's Business Daily on MSN12d
ResMed Among Top Stocks For Recent And Long-Term Profit GrowthResMed showed 29% EPS growth last quarter. Sales gains came in at 10%. ResMed earns the No. 6 rank among its peers in the ...
Morgan Stanley analyst David Bailey initiated coverage of ResMed (RMD) with an Overweight rating and $280 price target The company has a ...
For 35 years, Resmed has pioneered innovations in respiratory therapy, including CPAP therapy and digital health solutions. The company’s last major brand update in 2014 marked its shift to ...
ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results